Correlation Between Abnova Taiwan and SCI Pharmtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abnova Taiwan and SCI Pharmtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abnova Taiwan and SCI Pharmtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abnova Taiwan Corp and SCI Pharmtech, you can compare the effects of market volatilities on Abnova Taiwan and SCI Pharmtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abnova Taiwan with a short position of SCI Pharmtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abnova Taiwan and SCI Pharmtech.

Diversification Opportunities for Abnova Taiwan and SCI Pharmtech

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Abnova and SCI is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Abnova Taiwan Corp and SCI Pharmtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCI Pharmtech and Abnova Taiwan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abnova Taiwan Corp are associated (or correlated) with SCI Pharmtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCI Pharmtech has no effect on the direction of Abnova Taiwan i.e., Abnova Taiwan and SCI Pharmtech go up and down completely randomly.

Pair Corralation between Abnova Taiwan and SCI Pharmtech

Assuming the 90 days trading horizon Abnova Taiwan Corp is expected to under-perform the SCI Pharmtech. But the stock apears to be less risky and, when comparing its historical volatility, Abnova Taiwan Corp is 1.25 times less risky than SCI Pharmtech. The stock trades about -0.19 of its potential returns per unit of risk. The SCI Pharmtech is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  8,850  in SCI Pharmtech on August 29, 2024 and sell it today you would earn a total of  700.00  from holding SCI Pharmtech or generate 7.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.41%
ValuesDaily Returns

Abnova Taiwan Corp  vs.  SCI Pharmtech

 Performance 
       Timeline  
Abnova Taiwan Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abnova Taiwan Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
SCI Pharmtech 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in SCI Pharmtech are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, SCI Pharmtech may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Abnova Taiwan and SCI Pharmtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abnova Taiwan and SCI Pharmtech

The main advantage of trading using opposite Abnova Taiwan and SCI Pharmtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abnova Taiwan position performs unexpectedly, SCI Pharmtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCI Pharmtech will offset losses from the drop in SCI Pharmtech's long position.
The idea behind Abnova Taiwan Corp and SCI Pharmtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume